TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.
Clinical trial NCT00736905 · COMPLETED
Trial details
- NCT number
- NCT00736905
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2009-09-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.